Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
London Health Sciences Centre, London, Ontario, Canada
BMJ Case Rep. 2022 May 4;15(5):e236989. doi: 10.1136/bcr-2020-236989.
The simultaneous diagnosis of colonic lymphoma and adenocarcinoma in the same location is rare and presents challenges in its treatment considerations, especially in elderly patients. While previous cases have been described, there is little consistency in treatment regimens, and outcomes are generally poor. We describe the case of a man in his late 80s who presented with primary cecal and colonic B cell lymphoma, treated with R-mini-CHOP chemotherapy, but was found to have a residual adenocarcinoma in the cecum after treatment that was then successfully resected. The patient remains alive and well 3 years postoperation. This case highlights the need to consider lymphoma as a possible diagnosis for any colonic mass, and the need to consider rebiopsy of residual abnormal-appearing tissue postchemotherapy to confirm the diagnosis. Moreover, our report affirms that aggressive, curative-intent treatment with age-adjusted chemotherapy, and subsequent surgical resection is feasible for certain elderly patients with dual malignant diagnoses.
同时诊断出同一部位的结肠淋巴瘤和腺癌较为罕见,在治疗考虑方面具有挑战性,尤其是在老年患者中。虽然之前已经有过病例描述,但治疗方案并不一致,且结果通常较差。我们描述了一位 80 多岁的男性患者,他患有原发性盲肠和结肠 B 细胞淋巴瘤,接受了 R-mini-CHOP 化疗,但在治疗后发现盲肠中仍有残留的腺癌,随后成功切除。患者术后 3 年仍存活且状况良好。该病例强调需要将淋巴瘤视为任何结肠肿块的可能诊断,并需要考虑对化疗后异常外观组织进行再次活检以确认诊断。此外,我们的报告证实,对于某些患有双重恶性诊断的老年患者,采用年龄调整化疗的积极、治愈性治疗以及随后的手术切除是可行的。